阿尔茨海默病中脑灌注SPECT与不同标记后延迟动脉自旋标记MRI的头对头视觉比较
在33例阿尔茨海默病或阿尔茨海默病所致轻度认知障碍患者中,比较标记后延迟1.5秒和2.5秒的动脉自旋标记MRI与脑灌注SPECT对脑血流的视觉评估。PLD1.5和PLD2.5图像分别有84.9%和9%显示晚期阿尔茨海默病典型模式,三者视觉评估明显不同,PLD1.5显示广泛脑血流减低可能源于早期灌注,PLD2.5受早期灌注影响较小但病理发现少于SPECT。
要点
- PLD1.5图像84.9%显示晚期阿尔茨海默病典型模式,PLD2.5仅9%。
- PLD1.5显示广泛脑血流减低,可能反映早期灌注效应。
- PLD2.5受早期灌注影响较小,但病理发现少于SPECT。
核心结论
- 动脉自旋标记MRI与SPECT在阿尔茨海默病脑血流视觉评估中存在明显差异,PLD1.5可能受早期灌注影响而显示广泛减低,PLD2.5病理发现少于SPECT;这些差异在视觉评估中需仔细考虑,尚需进一步研究明确阿尔茨海默病相关动脉自旋标记MRI改变模式。
研究设计与样本
- 在33例阿尔茨海默病或阿尔茨海默病所致轻度认知障碍患者中,采用标记后延迟1.5秒和2.5秒的动脉自旋标记MRI及脑灌注SPECT获取脑血流图像,对22个脑区进行视觉评估并记录阿尔茨海默病诊断信心。
关键影像表现/征象
- PLD1.5图像中84.9%显示晚期阿尔茨海默病典型模式,即双侧顶叶、颞叶和额叶脑血流减低。
- PLD2.5图像中9%显示晚期阿尔茨海默病典型模式。
- PLD1.5显示广泛脑血流减低,可能源于早期灌注。
- PLD2.5似乎不受早期灌注影响,但病理发现少于SPECT。
诊断标准与关键数值
- 晚期阿尔茨海默病典型模式定义为双侧顶叶、颞叶和额叶脑血流减低。
- PLD1.5图像中84.9%显示该典型模式,PLD2.5图像中9%显示该典型模式。
临床应用与阅片要点
- 在阿尔茨海默病脑血流视觉评估中,需仔细考虑动脉自旋标记MRI不同标记后延迟与SPECT之间的差异。
- PLD1.5显示的广泛脑血流减低可能反映早期灌注效应。
- PLD2.5似乎受早期灌注影响较小,但病理发现少于SPECT。
局限性
- 原文结论指出尚需进一步研究明确阿尔茨海默病相关动脉自旋标记MRI改变模式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Arterial spin-labeling MR imaging has been recently developed as a noninvasive technique with magnetically labeled arterial blood water as an endogenous contrast medium for the evaluation of CBF. Our aim was to compare arterial spin-labeling MR imaging and SPECT in the visual assessment of CBF in patients with Alzheimer disease.
MATERIALS AND METHODS: In 33 patients with Alzheimer disease or mild cognitive impairment due to Alzheimer disease, CBF images were obtained by using both arterial spin-labeling-MR imaging with a postlabeling delay of 1.5 seconds and 2.5 seconds (PLD1.5 and PLD2.5, respectively) and brain perfusion SPECT. Twenty-two brain regions were visually assessed, and the diagnostic confidence of Alzheimer disease was recorded.
RESULTS: Among all arterial spin-labeling images, 84.9% of PLD1.5 and 9% of PLD2.5 images showed the typical pattern of advanced Alzheimer disease (ie, decreased CBF in the bilateral parietal, temporal, and frontal lobes). PLD1.5, PLD2.5, and SPECT imaging resulted in obviously different visual assessments. PLD1.5 showed a broad decrease in CBF, which could have been due to an early perfusion. In contrast, PLD2.5 did not appear to be influenced by an early perfusion but showed fewer pathologic findings than SPECT.
CONCLUSIONS: The distinctions observed by us should be carefully considered in the visual assessments of Alzheimer disease. Further studies are required to define the patterns of change in arterial spin-labeling-MR imaging associated with Alzheimer disease.
引用
- Kaneta T, Katsuse O, Hirano T, et al. Head-to-Head Visual Comparison between Brain Perfusion SPECT and Arterial Spin-Labeling MRI with Different Postlabeling Delays in Alzheimer Disease. AJNR Am J Neuroradiol. 2017. PMID: 28572147. doi:10.3174/ajnr.A5238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。